Shire Pharmaceuticals Group plc Confident of Approval for Vyvanse in Adults

LONDON, Feb 21 (Reuters) - Shire said on Thursday it was happy with the performance of its biggest new drug hope, Vyvanse for attention deficit hyperactivity disorder (ADHD), and confident it will be approved this year to treat adults.